ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: New DCCP Director To BE Named Soon; Creech, Owens Head AACR, ASC; Carbone, Moertel Next

April 14, 1978

ACS Approves New Workplaces Intervention Cancer Control Program

April 17, 1992

House Panel Recommends $642 Million Increase For NIH; $31 Million Increase For NCI

July 21, 1995

Reader Finds Letter insulting to Ethic Group

February 16, 1996

Funding Opportunities.

June 28, 2002

DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal

November 4, 1983